4 Healthcare Stock Reports on Deck

Humana, Inc. (NYSE:HUM) will unveil its latest earnings on Monday, April 30, 2012. The average estimate of analysts is for net income of $1.53 per share, a decline of 1.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.90. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.53 during the last month. Analysts are projecting profit to rise by 2.3% compared to last year’s $8.

The company missed estimates last quarter after beating forecasts in the prior two. In the fourth quarter of the last fiscal year, the company reported profit of $1.12 per share versus a mean estimate of net income of $1.20 per share. In the third quarter of the last fiscal year, the company beat estimates by 52 cents. Analysts predict a rise of 9.8% in revenue from the year-earlier quarter to $10.09 billion.

McKesson Corp (NYSE:MCK) will unveil its latest earnings on Monday, April 30, 2012. The average estimate of analysts is for net income of $2.06 per share, a rise of 24.1% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $2.07. Between one and three months ago, the average estimate moved down. It has risen from $2.05 during the last month. Analysts are projecting profit to rise by 29.8% versus last year to $6.36.

The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting profit of $1.40 per share against a mean estimate of net income of $1.38 per share. Analysts predict a rise of 5.4% in revenue from the year-earlier quarter to $30.4 billion.

NuVasive, Inc. (NASDAQ:NUVA) will unveil its latest earnings on Monday, April 30, 2012. The average analyst estimate is for net income of 7 cents per share, a decline of 30% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 8 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 7 cents during the last month. Analysts are projecting profit to rise by 19% versus last year to 47 cents.

The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 4 cents, reporting profit of 15 cents per share against a mean estimate of net income of 11 cents per share. On average, analysts predict $143.6 million in revenue this quarter, a rise of 15.4% from the year-ago quarter. Analysts are forecasting total revenue of $616.2 million for the year, a rise of 14% from last year’s revenue of $540.5 million.

Watson Pharmaceuticals, Inc. (NYSE:WPI) will unveil its latest earnings on Monday, April 30, 2012. The average estimate of analysts is for net income of $1.60 per share, a rise of 79.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.53. Between one and three months ago, the average estimate moved up. It has risen from $1.58 during the last month. For the year, analysts are projecting profit of $5.75 per share, a rise of 20.5% from last year.

Last quarter, the company beat estimates by 2 cents, coming in at net income of $1.77 a share versus the estimate of profit of $1.75 a share. It marked the fourth straight quarter of beating estimates. Analysts are projecting a rise of 68.9% in revenue from the year-earlier quarter to $1.48 billion.